06/13/2026
In case you missed it: the Canadian Rare Disease Network recently submitted a response to Health Canada’s consultation on clinical trial regulations, contributing perspectives to help ensure the realities of rare disease are considered in the future of research and access in Canada.
At ALS Action Canada, we know meaningful progress happens when patients, caregivers, researchers, clinicians, and organizations work together to strengthen the rare disease landscape.
“At CRDN, we believe progress in rare disease depends on strong coordination across research, care, policy, and patient communities. Thoughtful modernization of Canada’s clinical trial framework is one important part of making innovation more responsive to the realities and needs of people living with rare diseases.” – Canadian Rare Disease Network (CRDN)
We encourage our community to learn more about the work of the Canadian Rare Disease Network and stay informed about developments across Canada’s rare disease ecosystem.
Read more: [https://canadianrdn.ca/crdn-submits-response-to-health-canadas-consultation-on-clinical-trial-regulations/]